Chrousos Phaedra 4
4 · Vanda Pharmaceuticals Inc. · Filed Jun 12, 2023
Insider Transaction Report
Form 4
Chrousos Phaedra
Director
Transactions
- Award
Common Stock
2023-06-08+17,307→ 42,238 total - Award
Stock Option (Right to Buy)
2023-06-08+33,960→ 33,960 totalExercise: $6.50Exp: 2033-06-07→ Common Stock (33,960 underlying)
Footnotes (2)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 8, 2024, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.
- [F2]This option vests and becomes exercisable with respect to 100% of the option shares on June 8, 2024, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.